Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Current Cardiology Reports|September 12, 2000
Platelet activation in acute myocardial infarction and the rationale for combination therapyI Conde-Pozzi, N KleimanMicrosystems & Nanoengineering|September 27, 2021
Optical actuation of a micromechanical photodiode via the photovoltaic-piezoelectric effectA Rampal, R N KleimanOptics Express|March 17, 2019
Single-beam lifetime measurements via self-induced optical absorptionKevin M W Boyd, Rafael N KleimanScience (New York, N.Y.)|March 10, 2001
Quantum mechanical actuation of microelectromechanical systems by the Casimir forceH B Chan, V A Aksyuk, R N Kleiman, et al.The American Journal of Cardiology|November 15, 1993
Lack of usefulness of prolonged bleeding times in predicting hemorrhagic events in patients receiving the 7E3 glycoprotein IIb/IIIa platelet antibody. The TAMI Study GroupM M Bernardi, R M Califf, N Kleiman, et al.Physical Review Letters|December 12, 2001
Nonlinear micromechanical Casimir oscillatorH B Chan, V A Aksyuk, R N Kleiman, et al.Journal of the American College of Cardiology|July 1, 1992
Heparin-induced prolongation of partial thromboplastin time after thrombolysis: relation to coronary artery patency. HART InvestigatorsJ Hsia, N Kleiman, F Aguirre, et al.The New England Journal of Medicine|November 22, 1990
A comparison between heparin and low-dose aspirin as adjunctive therapy with tissue plasminogen activator for acute myocardial infarction. Heparin-Aspirin Reperfusion Trial (HART) InvestigatorsJ Hsia, W P Hamilton, N Kleiman, et al.The American Journal of Cardiology|February 1, 1988
Relation of left ventricular dilation during acute myocardial infarction to systolic performance, diastolic dysfunction, infarct size and locationA A Seals, C M Pratt, J J Mahmarian, et al.Journal of the American College of Cardiology|May 1, 1992
Confronting the issues of patient safety and investigator conflict of interest in an international clinical trial of myocardial reperfusion. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO) Steering CommitteeE J Topol, P Armstrong, F Van de Werf, et al.Pageof 2